Updated
May 2024
NAT3 allele (haplotype)(a) |
Nucleotide change(s)(b) |
Amino acid change(s)(b) |
Organism |
Literature |
(MOUSE)Nat3*1 |
Reference |
Reference |
Mouse |
|
(MUSMC)Nat3*2 |
c.238G>A c.607_608delinsCA |
p.Ala80Thr p.Trp203Gln |
Mouse |
|
(MUSSP)Nat3*3 |
c.147A>G c.162C>T c.238G>A c.295T>C c.413C>T c.511T>C c.607_608delinsCA c.638G>A c.796G>A c.857T>C |
p.Glu49= p.Asp54= p.Ala80Thr p.Cys99Arg p.Thr138Ile p.Ser171Pro p.Trp203Gln p.Arg213Gln p.Val266Ile p.Val286Ala |
Mouse |
|
(RAT)Nat3*1 |
Reference |
Reference |
Rat |
|
(RAT)Nat3*2 |
c.619G>T |
p.Ala207Ser |
Rat |
(a)
The gene symbols are assigned according to the current guidelines
of the NAT Gene Nomenclature
Committee [1]. The alleles of rodents are written as
Nat (first letter uppercase and second and third letter lowercase). The
alleles of all other species are all uppercase (e.g. NAT).
(b)
The position of SNPs in each
ORF is determined relative to the A of the ATG translation initiation codon,
which is always considered as number 1. The first methionine of each NAT
protein is amino acid number 1, with polymorphic amino acid positions
determined accordingly. The reference allele of each NAT3 gene (usually
the wild type allele or the first allele identified in a specific organism) is
assigned symbol NAT3*1.
(c)
Studied western European
house mouse (Mus musculus)
laboratory strains: i) inbred C57Bl/6J [2-5], Balb/c
[2], C3H/HeJ [3], 129/Ola
[4], CBA [4], A/J [2-5] and A/HeJ [3], ii)
outbred PO [4] and TO [4].
Also, the wild-derived inbred strains Mus musculus castaneus (southestern
Asian house mouse) and Mus spretus (western wild mouse) [4].
For new
submissions or enquiries, please contact Dr. Sotiria Boukouvala (sboukouv@mbg.duth.gr).
[1] Hein,
D.W.; Boukouvala, S.; Grant, D.M.; Minchin, R.F. and Sim, E. (2008) Changes
in consensus arylamine N-acetyltransferase
gene nomenclature. Pharmacogenet. Genomics 18(4),
367-368.
[2] Kelly, S.L. and Sim, E. (1994) Arylamine N-acetyltransferase in Balb/c mice: identification of a novel mouse isoenzyme by cloning and expression in vitro. Biochem. J. 302(2), 347-353.
[3] Fretland,
A.J.; Doll, M.A.; Gray, K.; Feng, Y. and Hein, D.W. (1997) Cloning,
expression and recombinant expression of
[4] Boukouvala,
S.; Price, N. and Sim, E. (2002) Identification and functional
characterization of novel polymorphisms associated with the genes for arylamine
N-acetyltransferases in mice. Pharmacogenetics 12(5), 385-394.
[5] Estrada-Rodgers, L.; Levy, G.N. and Weber, W.W. (1998) Substrate selectivity of mouse N-acetyltransferase 1, 2, and 3 expressed in COS-1 cells. Drug Metab. Dispos. 26(5), 502-505.
[6] Walraven,
J.M.; Doll, M.A. and Hein, D.W. (2006) Identification and characterization
of functional rat arylamine N-acetyltransferase
3: comparisons with rat arylamine N-acetyltransferases
1 and 2. J. Pharmacol. Exp. Ther. 319(1), 369-375.
[7] Walraven,
J.M.; Barker, D.F.; Doll, M.A. and Hein, D.W. (2007) Tissue expression
and genomic sequences of rat N-acetyltransferases
rNat1, rNat2, rNat3, and
Functional characterization of a novel rNat3*2
genetic variant. Toxicol. Sci. 99(2), 413-421.